Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by elgin1on Apr 13, 2017 10:43am

221 Views

Post# 26117714

Hemophilia clarification

The European collaboration for hemophilia involves stem cells from the patient itself for factor 8 that are put iNto SVA device . So no anti rejection drugs. The other collaboration involves microencapsulation of factor 8 stem cells not from the patient. Hemophilia is a $9 Billion dollar market annually or $200 k per patient per year .

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment